Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-08-18FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA, a combination inhaled corticosteroid and long-acting beta-agonist from GlaxoSmit…
-
FDA approval · 2021-08-18FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) [Phase 2]
Phase 2 dose-ranging study update for CHF 1531 in asthma completed with posted results.
-
FDA approval · 2021-08-13FDA Approved: ARIDOL BRONCHIAL CHALLENGE TEST KIT — Supplemental Application (Methapharm, Inc.)
FDA approved a supplemental application for the ARIDOL Bronchial Challenge Test Kit (mannitol) from Methapharm, Inc.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients. [Phase 4]
Phase 4 clinical trial update focusing on flow cytometry analysis of eosinophils in patients with severe asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-07-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Aurobindo Pharma Limited to market Montelukast sodium as a generic product.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Tezepelumab Home Use Study [Phase 3]
Phase 3 trial update for tezepelumab home-use study in asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Anti-viral Effects of Azithromycin in Patients With Asthma and COPD [Phase 4]
A Phase 4 clinical trial investigates the anti-viral effects of azithromycin in patients with asthma and chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Benralizumab Initiated During Severe Asthma Attack [Phase 2]
Phase 2 clinical trial update exploring benralizumab initiation during a severe asthma attack.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study) [Phase 3]
A Phase 3 clinical trial update aimed at reducing diagnostic error to improve patient safety in COPD and asthma has completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Phase 4]
Phase 4 clinical trial update on the immunologic basis of anti-IgE therapy in patients with asthma and related allergic conditions.
-
FDA approval · 2021-07-09FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental NDA for Fluticasone Propionate and Salmeterol (Teva) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation [Phase 4]
A Phase 4 trial evaluating intramuscular epinephrine as an adjunctive treatment for severe pediatric asthma exacerbations has completed, wit…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge [Phase 2]
Phase 2 study assessing a single dose of REGN1908-1909 to reduce bronchoconstriction after cat allergen exposure in cat-allergic patients wi…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children [Phase 4]
Phase 4 trial exploring the relationship between intestinal microecology and allergic diseases in children.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Probiotics and Infections in Conscripts in Military Service [NA]
Clinical trial completed evaluating probiotics for respiratory and gastrointestinal infections in conscripts; results posted.
-
FDA approval · 2021-06-03FDA Approved: THEOPHYLLINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Theophylline as a new original ANDA, enabling a generic Theophylline product. Theophylline is a bronchodilator used …
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Effects of Anti-TSLP in Patients With Asthma [Phase 2]
Phase 2 clinical trial evaluating an anti-TSLP agent in asthma has completed.
-
FDA approval · 2021-06-01FDA Approved: ALBUTEROL SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original application for albuterol sulfate. This approval makes a generic albuterol sulfat…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Predicting the Response to Montelukast by Genetic Variation in Asthmatics [Phase 3]
Phase 3 trial investigating how genetic variation predicts response to montelukast in asthmatics has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia [Phase 4]
Phase 4 clinical trial update evaluating strategies to reduce acute care burden of childhood asthma on health services in British Columbia.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma [NA]
A completed pediatric trial comparing breath-enhanced and T-Piece nebulizers for acute asthma; results posted in 2021. No disease-specific e…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. [Phase 3]
Phase 3 trial assessing efficacy and safety of QAW039 in severe asthma inadequately controlled with standard therapy has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients [Phase 2]
Phase 2 study evaluating LOU064 for inadequately controlled asthma was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Reducing Asthma Morbidity In High Risk Minority Preschool Children [NA]
Clinical trial update on reducing asthma morbidity in high-risk minority preschool children has completed with posted results.